Episode # 287 • 11 Aug 2026
Unified Airway: Unified Biology, Unified Inflammation
Can viewing the airway as one connected system change the future of respiratory care and improve patient outcomes? On this episode of the BackTable ENT & Allergy Podcast, Dr. Cedric Jamie Rutland, pulmonary and critical care medicine physician, joins Dr. Basil Kahwash to discuss the unified airway hypothesis and its implications for clinical care. They explore how upper and lower airway inflammation are closely linked, and why multidisciplinary collaboration is essential for treating the whole patient.
Timestamps
00:00 - Introduction
05:06 - Understanding the Unified Airway
14:27 - Decoding Asthma Biomarkers
20:34 - Endotyping in Clinical Practice
26:36 - Addressing Asthma Symptom and “Outgrowing” Asthma
32:13 - Strategies for Precision Biologics
34:23 - Navigating Insurance and Treatment Indications
35:36 - Treating the Whole Patient and Breaking Down Specialty Silos
46:07 - Effective Patient Communication
51:36 - Asthma Lightning Round
57:33 - Biologics and Airway Remodeling
1:00:00 - Closing Thoughts
Resources
You may also like
More about this episode
The conversation covers the biology of type II inflammation, the use of biomarkers and biologics for more personalized treatment, and practical strategies for overcoming insurance barriers and specialty silos. Dr. Rutland shares insights on patient communication, the limitations of current diagnostics, and the impact of chronic inflammation on systemic disease. The episode highlights the need for ENT, allergy, and pulmonology teams to work together and embrace a connected view of airway disease to achieve better patient outcomes.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.